CEBPA and acute myeloid leukemia: Two concurrent mutational signatures in CSF3R (Colony Stimulating Factor 3 Receptor) and CEBPA (CCAAT Enhancer Binding Protein Alpha) that are related to higher relapse rates have been identified in patients with acute myeloid leukemia.